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Available online 27 July 2007Abstract—An eﬃcient synthesis of tetrazole analogues of amino acids starting from Na-Fmoc amino acid in a three-step protocol is
reported. The free amino tetrazoles were obtained in good yields and with excellent purity after removal of the Fmoc group. The
synthesis of analogues of aspartic and glutamic acids in which the 5-tetrazolyl moiety is inserted at the b/c carboxyl group starting
from Fmoc-Asn and Fmoc-Gln and the incorporation of these tetrazoles into peptides are also described.
 2007 Elsevier Ltd. All rights reserved.Tetrazoles, being an interesting class of heterocycles,
ﬁnd a wide range of applications as drugs in pharmaceu-
ticals,1 cis-peptide bond mimics2 and bioisosteres3 for
carboxylic acids. They are important precursors in
medicinal chemistry owing to their increased resistance
towards metabolic degradation pathways and have
found increasing applications as catalysts4 in asymmet-
ric synthesis. Tetrazoles have also been utilized in orga-
nometallic chemistry as eﬀective stabilizers of
metallopeptide structures and as peptide chelating
agents.5
The selective modiﬁcation of amino acid chains in pep-
tides and proteins is important in many areas of chemis-
try such as organic synthesis, the irreversible inhibition
of enzymes and in the improvement of pharmacokinetic
properties of peptide based drugs. Since, the acidity of
the tetrazole group corresponds closely with that of a
carboxylic acid, replacement of the C-terminal amino
acid residue in biologically active peptides with a tetra-
zole analogue would create an interesting class of com-
pounds for structure function relationship studies.0040-4039/$ - see front matter  2007 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2007.07.129
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* Corresponding author. Tel.: +91 80 22961339; e-mail: hariccb@
rediﬀmail.comIndeed, isosteric displacement of the C-terminus carbox-
ylic acid with a tetrazole often preserves or improves the
biological activity of the parent peptides and their
mimetics.
Conventionally, 5-substituted tetrazoles are synthesized6
by [2+3] cycloaddition of an azide and a nitrile. How-
ever, disadvantages of these synthetic routes involve
the use of expensive and toxic metals, strong Lewis acids
and the in situ generation of hydrazoic acid which is
highly toxic and explosive in nature. An alternative
route to overcome some of these shortcomings was nec-
essary. Sharpless et al.,7 reported an eﬃcient protocol
for the synthesis of tetrazoles using sodium azide and
zinc bromide in water/2-propanol mixture at reﬂux
employing Z-protected amino acids as key synthons.
Alternatively, tetrazole analogues of amino acids have
been reported by Grzonka et al.,8 from Z-protected ami-
no nitriles using sodium azide and aluminium chloride
in tetrahydrofuran at reﬂux. In continuation of our
interest in incorporating a tetrazole heterocyclic moiety
into amino acids and thereby peptides, we describe here
our eﬀorts to isolate amino free tetrazoles of a-amino
acids employing an Fmoc-protection strategy and their
incorporation into peptides. Ley9 recently reported the
utility of free amine proline tetrazole as a catalyst in
asymmetric synthesis. This catalyst was prepared after
deprotection of the Z-group from Z-proline tetrazole
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hydrogenator.10 Although this process has led to com-
plete removal of the Z-group in 4 h, the expensive nature
of palladium, the special apparatus and the diﬃculties
encountered in isolating the product are some of the lim-
itations in scaling-up this protocol. In addition, our
eﬀorts to obtain amino free tetrazoles from Boc-Phe
tetrazole using TFA were unsuccessful. In this context,
the use of a Fmoc protection strategy was of particular
interest since the Fmoc group can be easily removed un-
der mild basic conditions in solution and also permits
the use of Trt and tbutyl groups for side chain protec-
tion, which can also be cleaved under mild conditions.11
We have envisaged a simple, four-step protocol for the
synthesis of amino free tetrazole analogues of amino
acids employing Fmoc chemistry in solution phase.
Pozdnev et al.12 reported the synthesis of Boc/Z-amino
acid amides including Fmoc-Phe and Leu using the di-
tert-butyl pyrocarbonate [(Boc)2O]-pyridine system. A
similar protocol with required modiﬁcations was
employed for our synthesis of Fmoc-protected amino
acid carboxamides (Scheme 1). Subsequent dehydration
of the amides to the corresponding nitriles was achieved
in excellent yields employing triﬂuoroacetic anhydride.13
This reagent was best suited for our protocol since DCC
mediated dehydration requires the use of pyridine as a
solvent, a strategy that does not fully support Fmoc-
chemistry. Another dehydrating reagent, cyanuric chlo-
ride was not used because the synthetic protocol wasFmocNH
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Scheme 1. Reagents and conditions: (a) (Boc)2O, pyridine, NH4HCO3, rt, 5 h
85–95%; (c) NaN3, ZnBr2, water/2-propanol (2:1), 80 C, 16 h, 80–90%; (d)
Table 1. Na-protected tetrazole analogues of amino acids and amine free tet
Entry Fmoc-amino tetrazolea Yield (%) Mp (C) Massb (obs/ca
1 Fmoc-GlyT 89 181 321.3312 (321.
2 Fmoc-AlaT 91 189 335.3579 (335.
3 Fmoc-ValT 85 207 363.4147 (363.
4 Fmoc-LeuT 86 202 377.4379 (377.
5 Fmoc-IleT 88 219 377.4380 (377.
6 Fmoc-PheT 90 204 411.4526 (411.
7 Fmoc-Ser (OBz)T 82 223 441.4832 (441.
8 Fmoc-D-PhgT 84 211 397.4275 (397.
9 Fmoc-L-PhgT 82 186 397.4282 (397.
10 Fmoc-MetT 89 193 395.4764 (395.
11 Fmoc-ProT 81 180 361.3949 (361.
12 Fmoc-Asp (OBz)T 79 227 469.4902 (469.
13 Fmoc-Glu (OBz)T 81 232 483.5164 (483.
a T corresponds to Tetrazole.
b High resolution mass spectrometry (HRMS).aimed at keeping the a-carboxyl group free in the case
of side chain-derived tetrazole analogues. A characteris-
tic peak around 2240 cm1 in the IR spectrum con-
ﬁrmed the presence of a nitrile group. All the Fmoc-a-
amino nitriles prepared were obtained as crystalline sol-
ids. The methodology introduced by Sharpless et al.,7
for the conversion of a-amino nitriles to 5-substituted
tetrazoles14 was found to be applicable in the case of
the Fmoc-amino nitriles described herein. The reaction
proceeds by addition of sodium azide and a catalytic
amount of zinc bromide to a-amino nitriles in water/2-
propanol (2:1) mixture at reﬂux for 16 h. A simple
work-up involving acidiﬁcation and extraction yielded
the corresponding tetrazoles as pure solids in yields
around 80–90%.
The Fmoc-group was deprotected using diethylamine in
CH2Cl2 in 30 min to yield a-amino tetrazoles.15 After
evaporation of the solvent and trituration with ether,
the compounds were isolated as pure solids (Table 1).
The reaction sequence was found to be free from racemi-
zation16 as determined by chiral HPLC of the methyl-
ated derivatives of the corresponding tetrazoles.
Further, the utility of Fmoc chemistry for inserting the
tetrazole unit into the b/c carboxylic position of aspartic
and glutamic acids was demonstrated (Scheme 2). It was
envisaged that the carboxamido group present in the
side chains of asparagine and glutamine could be readily
exploited for the incorporation of a tetrazole moiety inNH2 FmocNH
R
CN
FmocNH
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N
NH
NN
b
c
NH
N
d
, 70–80%; (b) triﬂuoroacetic anhydride–pyridine (1:1), THF, 0 C, 3 h,
diethylamine, CH2Cl2, 30 min, 80–94%.
razoles
lc) Free amino
tetrazolea
Yield (%) Mp (C) Massb (obs/calc)
3333) GlyT 93 274 99.0932 (99.0946)
3598) AlaT 90 257 113.1237 (113.1211)
4130) ValT 88 273 141.1720 (141.1743)
4396) LeuT 89 262 155.2023 (155.2009)
4396) IleT 90 269 155.2001 (155.2009)
4558) PheT 94 278 189.2143 (189.2171)
4818) Ser(OBz)T 85 243 219.2405 (219.2431)
4292) D-PhgT 87 181 175.1933 (175.1905)
4292) L-PhgT 85 202 175.1919 (175.1905)
4780) MetT 87 233 173.2364 (173.2393)
3971) ProT 83 249 139.1559 (139.1584)
4919) Asp(OBz)T 81 227 247.2511 (247.2532)
5185) Glu(OBz)T 84 178 261.2768 (261.2798)
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Scheme 2. Reagents and conditions: (a) Triﬂuoroacetic anhydride–pyridine (1:1), THF, 0 C, 6 h, 70–80%; (b) NaN3, ZnBr2, water/2-propanol (2:1),
80 C, 16 h, 65–75%; (c) HBTU, DIEA, MeOH, DCM, 0 C! rt, 5 h, 80–90%.
Table 2. Synthesis of side chain derived tetrazole analogues of aspartic and glutamic acids and peptides
Entry Compound Yield (%) Mp (C) Massa (obs/calc)
1 Fmoc-Asp(T)-OH 76 202 379.3719 (379.3734)
2 Fmoc-Glu(T)-OH 79 190 393.3991 (393.4008)
3 Fmoc-Asp(T)-Leu-OCH3 66 163 506.5563 (506.5581)
4 Fmoc-Asp(T)-Ala-OCH3 71 213 464.4765 (464.4789)
5 Fmoc-Asp(T)-Gly-OCH3 74 178 450.4301 (450.4513)
6 Fmoc-Asp(T)-Phe-OCH3 69 185 540.5726 (540.5758)
7 Fmoc-Glu(T)-Leu-OCH3 71 157 520.5812 (520.5855)
8 Fmoc-Glu(T)-Ala-OCH3 73 192 478.5023 (478.5058)
9 Fmoc-Glu(T)-Gly-OCH3 76 183 464.4741 (464.4785)
a High resolution mass spectrometry (HRMS).
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synthesis using Fmoc-Asn-OMe and Fmoc-Gln-OMe,
it was found that the entire protocol could be carried
out starting from Fmoc-Asn/Gln.
A two-step protocol including conversion of a carbox-
amido group to a nitrile followed by cycloaddition
resulted in Fmoc-Asp(T)-OH and Fmoc-Glu(T)-OH in
76% and 79% yields, respectively, which were fully char-
acterized by 1H NMR, 13C NMR and mass spectral
studies (Table 2). The tetrazolyl acids were employed
as building blocks to prepare peptides possessing a tetra-
zole unit in the side chain. Fmoc-Asp(T)-OH or Fmoc-
Glu(T)-OH was coupled with amino acid methyl ester
hydrochlorides using the standard HBTU and DIEA
methods. The coupling was carried out at 0 C in
DCM and the reaction mixture was allowed to warm
to room temperature over 5 h. After work-up, the prod-
ucts were isolated as solids in yields around 80–90%.
In conclusion, tetrazole analogues of amino acids/pep-
tides have been synthesized through an Fmoc-amino
protection strategy. The use of Fmoc for amine protec-
tion facilitated the easy isolation of intermediate nitriles
and ﬁnal tetrazoles. Amino free tetrazoles were obtained
by deprotection of the Fmoc group under mild reaction
conditions. The tetrazole-containing unnatural amino
acids isosteric to Asp/Glu have been similarly synthe-
sized from Fmoc-Asn/Gln and utilized in the synthesis
of peptides. In all cases, the ﬁnal tetrazole products were
isolated in high yields and purities.Acknowledgements
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